Doximity Q1 revenue beats analyst estimates

Doximity

06/08/2026 21:16

Overview
US digital health platform's fiscal Q1 revenue rose 7% yr/yr, beating analyst expectations
Adjusted EBITDA for fiscal Q1 beat analyst expectations but declined 6% yr/yr
Net income for fiscal Q1 fell sharply from prior year, with margin narrowing to 16%

Outlook
Doximity sees Q2 revenue between $170 mln and $171 mln
Company expects Q2 adjusted EBITDA between $80.5 mln and $81.5 mln
Doximity updates FY27 revenue guidance to $671 mln–$681 mln

Result Drivers
USER ENGAGEMENT - Co reported record platform engagement and more than 30% yr/yr growth in workflow active prescribers
AI FEATURES - Co highlighted increased usage of AI-powered clinical tools, including top performance of its clinical AI assistant in a benchmark

Company press release: ID:nBw5Dny8Fa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$156.62 mln
$151.73 mln (18 Analysts)
Q1 Net Income
 
$24.32 mln
 
Q1 Adjusted EBITDA
Beat
$74.8 mln
$69.56 mln (18 Analysts)

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 12 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the software peer group is "buy"
Wall Street's median 12-month price target for Doximity, Inc. is $23.50, about 8.6% above its August 5 closing price of $21.63
The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 15 three months ago

Reuters Recommended Reads
Aug 4 - Hinge Health Q2 revenue jumps 53%, beats estimates
Aug 4 - Amwell Q2 revenue falls, co lifts low end of FY guidance 
Aug 5 - GoodRx Q2 revenue beats estimates; raises 2026 outlook

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)